| 000 | 01666 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513040518.0 | ||
| 264 | 0 | _c19931118 | |
| 008 | 199311s 0 0 eng d | ||
| 022 | _a0832-610X | ||
| 024 | 7 |
_a10.1007/BF03009699 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHardy, J F | |
| 245 | 0 | 0 |
_aLow-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients. _h[electronic resource] |
| 260 |
_bCanadian journal of anaesthesia = Journal canadien d'anesthesie _cJul 1993 |
||
| 300 |
_a625-31 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAprotinin _xadministration & dosage |
| 650 | 0 | 4 | _aBlood Coagulation Tests |
| 650 | 0 | 4 |
_aBlood Loss, Surgical _xprevention & control |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 | _aCardiac Surgical Procedures |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aErythrocyte Transfusion |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemoglobins _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 | _aPlatelet Transfusion |
| 650 | 0 | 4 | _aReoperation |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aDesroches, J | |
| 700 | 1 | _aBelisle, S | |
| 700 | 1 | _aPerrault, J | |
| 700 | 1 | _aCarrier, M | |
| 700 | 1 | _aRobitaille, D | |
| 773 | 0 |
_tCanadian journal of anaesthesia = Journal canadien d'anesthesie _gvol. 40 _gno. 7 _gp. 625-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03009699 _zAvailable from publisher's website |
| 999 |
_c7690849 _d7690849 |
||